- Acquired by The Richters for $2B, Jan 2001
About
Medinol is dedicated to the science of cardiovascular intervention. Founded in 1992, the company has been at the forefront of pioneering new stent system technology, delivering over 2,000,000 stents to date. Medinol's activities, including research, development, quality control, regulatory affairs, clinical trials, manufacturing, marketing, and sales, are conducted in-house. The company develops and markets a range of products including drug-eluting stents, bare metal stents, and implantable microsensors, with a focus on improving patient outcomes and procedural success in treating cardiovascular diseases. Medinol holds an extensive patent portfolio and maintains a commitment to scientific advances and health.
Headcount over time
Q&A
- What is Medinol's primary focus?
- Medinol is dedicated to the science of cardiovascular intervention, developing, manufacturing, and marketing medical devices like the EluNIR drug-eluting stent.
- What is the key product offered by Medinol?
- Medinol's key product is EluNIR, an elastomeric drug-eluting stent made from a thin cobalt-chrome alloy, known for its balance of flexibility, conformability, scaffolding, and low metal footprint.
- What technology does the EluNIR stent feature?
- The EluNIR stent features the novel Flexx catheter technology, which includes a visible metallic spring tip designed to improve flexibility and crossability during delivery.
- Where is Medinol headquartered?
- Medinol is headquartered in Jerusalem, Israel.
- When was Medinol founded?
- Medinol was founded in December 1992.
- In which sector does Medinol primarily operate?
- Medinol primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Drug Delivery.
- Does Medinol hold any patents?
- Yes, Medinol holds one patent.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Founded | 1992 |
|---|---|
| Employees (exact) | 125 |
| Offices | Colorado Springs; Tel Aviv-Yafo |
| Wikidata QID | Q97209200 |
Acquisitions & public offerings
Acquired by The Richters 2001-01 $2.0B
Radar intelligence
Patents
| EPO | 142 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | medinol.com |
|---|
Wikidata
| QID | Q97209200 |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512622994 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1992-12-23 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | רח 2184 8 תל אביב - יפו |